logo-loader
viewCello Health PLC

Full interview: Cello Health reports good growth in profits and strong cash flow

Cello Health PLC's (LON:CLL) Mark Scott tells Proactive London they've seen good growth in profits and strong cash flow for the first half of the year said that he's confident about the rest of the year too.

The group delivered net revenue of £54.5mln for the first six months of the year, which was up 6.8% on a year ago, with like-for-like constant currency net revenue up 4.5%.

Quick facts: Cello Health PLC

Price: 115.5 GBX

AIM:CLL
Market: AIM
Market Cap: £123.23 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cello Health PLC named herein, including the promotion by the Company of Cello Health PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Cello Health PLC running 'remarkably well' since going completely virtual

Cello Health PLC's (LON:CLL) Mark Scott tells Proactive's Andrew Scott they're coping well since first going completely remote and virtual. ''It's a lot of people, a thousand people, and we've done that successfully, all operating well and we've maintained a large number of global...

on 7/4/20

2 min read